• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    45.58 Down 1.32(2.81%) Apr 29, 4:00PM EDT
    |After Hours : 45.58 0.00 (0.00%) Apr 29, 4:55PM EDT
    Prev Close:46.90
    Open:46.73
    Bid:38.12 x 100
    Ask:50.00 x 100
    1y Target Est:67.13
    Beta:-0.025163
    Next Earnings Date: 5-May-16NBIX Earnings announcement
    Day's Range:45.09 - 47.47
    52wk Range:31.25 - 58.46
    Volume:704,468
    Avg Vol (3m):1,214,100
    Market Cap:3.95B
    P/E (ttm):N/A
    EPS (ttm):-1.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXDown 2.81%3.95B
    LLYDown 1.22%80.29B
    PFEDown 0.61%202.54B
    ABTDown 3.76%57.16B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):205.10
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-16) :-1.95
    Quarterly EPS Est (Mar-16) :-0.29
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):2.55

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback